INTELLIA THERAPEUTICS, INC. (NTLA) Operating margin 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) operating margin by fiscal year — reported operating income divided by reported revenue.
-651.7%FY2025 · since FY2016: -195.2% → -651.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -651.7% | +271.4 pp |
| FY2024 | -923.1% | +497.4 pp |
| FY2023 | -1420.5% | -541.5 pp |
| FY2022 | -879.0% | -68.7 pp |
| FY2021 | -810.4% | -574.9 pp |
| FY2020 | -235.5% | +11.3 pp |
| FY2019 | -246.8% | +51.8 pp |
| FY2018 | -298.6% | -32.3 pp |
| FY2017 | -266.3% | -71.2 pp |
| FY2016 | -195.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NTLA financial trends
NTLA RevenueNTLA Net incomeNTLA Net marginNTLA Gross profitNTLA Gross marginNTLA Operating incomeNTLA Operating cash flowNTLA Free cash flowNTLA Capital expendituresNTLA Return on equityNTLA Stock buybacksNTLA Dividends paidNTLA Total assetsNTLA Total liabilitiesNTLA Shareholders’ equityNTLA overview →